CEO Jean Jacques Bienaime sold $676K of BioMarin Pharmaceutical Inc.

Sold$676,320

$84.54Price

8,000Shares

−1%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Wed, Feb 17. Filed Thu, Feb 18, 9:45 PM ET, after the close. Not investment advice.